Alcon AG (ALC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Alcon AG stock (ALC) is currently trading at $75.26. Alcon AG PE ratio is 37.49. Alcon AG PS ratio (Price-to-Sales) is 3.57. Analyst consensus price target for ALC is $95.31. WallStSmart rates ALC as Underperform.
- ALC PE ratio analysis and historical PE chart
- ALC PS ratio (Price-to-Sales) history and trend
- ALC intrinsic value — DCF, Graham Number, EPV models
- ALC stock price prediction 2025 2026 2027 2028 2029 2030
- ALC fair value vs current price
- ALC insider transactions and insider buying
- Is ALC undervalued or overvalued?
- Alcon AG financial analysis — revenue, earnings, cash flow
- ALC Piotroski F-Score and Altman Z-Score
- ALC analyst price target and Smart Rating
Alcon AG
📊 No data available
Try selecting a different time range
ALC Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Alcon AG (ALC)
ALC trades 490% above its Graham fair value of $13.46, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Alcon AG (ALC) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, price/book, institutional own.. Concerns around return on equity and eps growth. Mixed signals suggest waiting for clearer direction before acting.
Alcon AG (ALC) Key Strengths (3)
Large-cap company with substantial market presence
Trading at 1.63x book value, attractively priced
67.82% held by institutions, strong professional interest
Supporting Valuation Data
Alcon AG (ALC) Areas to Watch (7)
Earnings declining -22.20%, profits shrinking
Very low returns on shareholder equity
Thin operating margins with cost pressures present
Modest revenue growth at 8.60%
Thin profit margins with limited profitability
Growth is fairly priced, not cheap, not expensive
Revenue is fairly priced at 3.57x sales
Supporting Valuation Data
Alcon AG (ALC) Detailed Analysis Report
Overall Assessment
This company scores 49/100 in our Smart Analysis, earning a D+ grade. Out of 10 metrics analyzed, 3 register as strengths (avg 8.3/10) while 7 fall into concern territory (avg 3.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Market Cap, Price/Book, Institutional Own.. Valuation metrics including Price/Book (1.63) suggest the stock is attractively priced.
The Bear Case
The primary concerns are EPS Growth, Return on Equity, Operating Margin. Some valuation metrics including PEG Ratio (1.70), Price/Sales (3.57) suggest expensive pricing. Growth concerns include Revenue Growth at 8.60%, EPS Growth at -22.20%, which may limit upside. Profitability pressure is visible in Return on Equity at 4.50%, Operating Margin at 11.70%, Profit Margin at 9.42%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 4.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 8.60% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. EPS Growth and Return on Equity are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ALC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ALC's Price-to-Sales ratio of 3.57x trades 16% below its historical average of 4.26x (6th percentile). The current valuation is 34% below its historical high of 5.37x set in Apr 2021, and 17% above its historical low of 3.05x in Mar 2020. Over the past 12 months, the PS ratio has compressed from ~4.8x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Alcon AG (ALC) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Alcon AG operates as a stable business with moderate growth and solid fundamentals. Revenue reached 10.4B with 9% growth year-over-year. Profit margins are thin at 9.4%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 489M in free cash flow and 658M in operating cash flow. Earnings are translating into actual cash generation.
Debt-to-equity ratio of 0.24 indicates a conservative balance sheet with 1.5B in cash.
ROE of 4.5% suggests the company isn't efficiently converting equity into profits.
What to Watch Next
Margin expansion: can Alcon AG push profit margins above 15% as the business scales?
Debt management: total debt of 5.2B is significantly higher than cash (1.5B). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Alcon AG.
Bottom Line
Alcon AG offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 10:02:24 AM
About Alcon AG(ALC)
NYSE
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.